Type 2 diabetes: Why we are winning the battle but losing the war? 2015 Kelly west award lecture

Diabetes Care

Volumn 39, Issue 5, 2016, Pages 653-663

  Venkat Narayan, K M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; COOPERATION; DIABETES CONTROL; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INDIA; INSULIN RELEASE; LOWEST INCOME GROUP; MEDICAL RESEARCH; MIDDLE INCOME GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PHENOTYPE; PREVALENCE; PUBLICATION; RISK REDUCTION; SOCIOECONOMICS; ADULT; AGED; DEVELOPING COUNTRY; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HEALTH SURVEY; INSULIN RESISTANCE; MIDDLE AGED; NUTRITION; YOUNG ADULT;

ADULT; AGED; BODY MASS INDEX; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HEALTH SURVEYS; HUMANS; INCIDENCE; INSULIN RESISTANCE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; YOUNG ADULT;

EID: 84964797776     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0205     Document Type: Article

References (97)

1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014 [Internet]. Available from http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 23 January 2016
2. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014;370:1514-1523
3. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U. S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012;35:1252-1257
4. Kennon B, Leese GP, Cochrane L, et al. Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 2012;35:2588-2590
5. Ikonen TS, Sund R, Venermo M, Winell K. Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study. Diabetes Care 2010;33:2598-2603
6. Narayan KM, Benjamin E, Gregg EW, Norris SL, Engelgau MM. Diabetes translation research: where are we and where do we want to be? Ann Intern Med 2004;140:958-963
7. Narayan KM, Gregg EW, Engelgau MM, et al. Translation research for chronic disease: the case of diabetes. Diabetes Care 2000;23:1794-1798
8. Garfield SA, Malozowski S, Chin MH, et al.; Diabetes Mellitus Interagency Coordinating Committee (DIMCC) Translation Conference Working Group. Considerations for diabetes translational research in real-world settings. Diabetes Care 2003;26:2670-2674
9. TRIAD Study Group. Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study. Diabetes Care 2010;33:940-947
10. Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med 2004;141:272-281
11. Mangione CM, Gerzoff RB, Williamson DF, et al.; TRIAD Study Group. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 2006;145:107-116
12. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008;23:588-594
13. Ettner SL, Thompson TJ, Stevens MR, et al.; TRIAD Study Group. Are physician reimbursement strategies associated with processes of care and patient satisfaction for patients with diabetes in managed care? Health Serv Res 2006;41:1221-1241
14. Karter AJ, Stevens MR, Herman WH, et al.; Translating Research Into Action for Diabetes Study Group. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2003;26:2294-2299
15. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-574
16. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-474
17. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U. S. diabetes care, 1999-2010. N Engl J Med 2013;368:1613-1624
18. Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA 2014;312:1218-1226
19. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290:1884-1890
20. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes Endocrinol 2014;2:867-874
21. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U. S., 2005-2050. Diabetes Care 2006;29:2114-2116
22. Narayan KM, Williamson DF. Prevention of type 2 diabetes: risk status, clinic, and community. J Gen Intern Med 2010;25:154-157
23. American Diabetes Association. Economic costs of diabetes in the U. S. in 2007. Diabetes Care 2008;31:596-615
24. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical spending. Health Aff (Millwood) 2004;23(Suppl.):W4-480-4-486
25. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation, 2015
26. Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KM. Rural diabetes prevalence quintuples over twenty-five years in low- and middleincome countries: a systematic review and meta-analysis. Diabetes Res Clin Pract 2012;96:271-285
27. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium, International Diabetes Federation, 2013
28. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
29. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
30. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297
31. Narayan KM, Gujral UP. Evidence tips the scale toward screening for hyperglycemia. Diabetes Care 2015;38:1399-1401
32. Fradkin JE, Roberts BT, Rodgers GP. What's preventing us from preventing type 2 diabetes? N Engl J Med 2012;367:1177-1179
33. Centers for Disease Control and Prevention (CDC). Awareness of prediabetes-United States, 2005-2010. MMWR Morb Mortal Wkly Rep 2013;62:209-212
34. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23:1563-1580
35. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87
36. American Diabetes Association. Standards of medical care in diabetesd-2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
37. U. S. Preventive Services Task Force. Screening for type 2 diabetes mellitus in adults: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:846-854
38. Narayan KM, Weber MB. Screening for hyperglycemia: the gateway to diabetes prevention and management for all Americans. Ann Intern Med 2015;162:795-796
39. Siu AL; U. S. Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015;163:861-868
40. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood) 2012;31:67-75
41. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med 2008;35:357-363
42. Sattin RW, Williams LB, Dias J, et al. Community trial of a faith-based lifestyle intervention to prevent diabetes among African-Americans. J Community Health 2016;41:87-96
43. Saaristo T, Moilanen L, Korpi-Hyövälti E, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: oneyear follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 2010;33:2146-2151
44. Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010;33:1484-1490
45. Moin T, Li J, Duru OK, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med 2015;162:542-548
46. Gregg EW, Boyle JP, Thompson TJ, Barker LE, Albright AL, Williamson DF. Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030. Popul Health Metr 2013;11:18
47. Satterfield DW, Volansky M, Caspersen CJ, et al. Community-based lifestyle interventions to prevent type 2 diabetes. Diabetes Care 2003;26:2643-2652
48. Siegel KR, Ali MK, Srinivasiah A, Nugent RA, Narayan KM. Do we produce enough fruits and vegetables to meet global health need? PLoS ONE 2014;9:e104059
49. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136:664-672
50. Narayan KM, Fagot-Campagna A, Imperatore G. Type 2 diabetes in children: a problem lurking for India? Indian Pediatr 2001;38:701-704
51. Dabelea D, Bell RA, D'Agostino RB Jr, et al.; Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA 2007;297:2716-2724
52. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005;116:473-480
53. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab 2002;15(Suppl. 2):737-744
54. Cunningham SA, Kramer MR, Narayan KM. Incidence of childhood obesity in the United States. N Engl J Med 2014;370:403-411
55. Foster GD, Linder B, Baranowski T, et al.; HEALTHY Study Group. A school-basedintervention for diabetes risk reduction. N Engl J Med 2010;363:443-453
56. Lobstein T, Jackson-Leach R, Moodie ML, et al. Child and adolescent obesity: part of a bigger picture. Lancet 2015;385:2510-2520
57. Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63
58. Sattar N, Gill JM. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol 2015;3:1004-1016
59. Mohan V, Deepa M, Deepa R, et al. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India - the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175-1178
60. Gujral UP, Narayan KM, Pradeepa RG, et al. Comparing type 2 diabetes, prediabetes, and their associated risk factors in Asian Indians in India and in the U. S.: the CARRS and MASALA Studies. Diabetes Care 2015;38:1312-1318
61. Oza-Frank R, Narayan KM. Overweight and diabetes prevalence among US immigrants. Am J Public Health 2010;100:661-668
62. Venkataraman R, Nanda NC, Baweja G, Parikh N, Bhatia V. Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol 2004;94:977-980
63. Lee JWR, Brancati FL, Yeh H-C. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011;34:353-357
64. Oza-Frank R, Ali MK, Vaccarino V, Narayan KM. Asian Americans: diabetes prevalence across U. S. and World Health Organization weight classifications. Diabetes Care 2009;32:1644-1646
65. Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985;291:1081-1084
66. Creatore MI, Moineddin R, Booth G, et al. Age- and sex-related prevalence of diabetes mellitus among immigrants to Ontario, Canada. CMAJ 2010;182:781-789
67. Patel S, Shivashankar R, Ali MK, et al. Is the "South Asian phenotype" unique to South Asians? Comparing cardiometabolic risk factors in the CARRS and NHANES studies. Glob Heart. In press
68. Maskarinec G, Grandinetti A, Matsuura G, et al. Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort. Ethn Dis 2009;19:49-55
69. Chan WB, Tong PCY, Chow CC, et al. The associations of body mass index, C-peptide and metabolic status in Chinese type 2 diabetic patients. Diabet Med 2004;21:349-353
70. Unnikrishnan R, Anjana RM, Mohan V. Diabetes in South Asians: is the phenotype different? Diabetes 2014;63:53-55
71. Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007;2:267-275
72. MacFarlane I, Bliss M, Jackson J, Williams G. Diabetes in its historical and social context. In Textbook of Diabetes. 2nd ed. Hoboken, NJ, Blackwell Scientific Publications, 1997
73. Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR 3rd, Aguilar RB. The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema. Diabetes Care 2016;39:179-186
74. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010;363:2339-2350
75. Abdul-Ghani MA, Tripathy D, De Fronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139
76. Nathan DM, Davidson MB, De Fronzo RA, et al.; American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759
77. Weber MB, Harish R, Staimez LR, et al. Reduction in diabetes incidence differs by prediabetes type in a randomized translational trial of prevention [Abstract]. Diabetes 2015;64(Suppl. 1A):LB46
78. Saito T, Watanabe M, Nishida J, et al.; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011;171:1352-1360
79. Staimez LR, Weber MB, Ranjani H, et al. Evidence of reduced β-cell function in Asian Indians with mild dysglycemia. Diabetes Care 2013;36:2772-2778
80. Mohan V, Amutha A, Ranjani H, et al. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther 2013;15:315-322
81. Gujral UP, Narayan KM, Kahn SE, Kanaya AM. The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study. J Diabetes Complications 2014;28:45-50
82. Ikehara S, Tabák AG, Akbaraly TN, et al. Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study. Diabetologia 2015;58:534-542
83. Kanaya AM, Herrington D, Vittinghoff E, et al. Understanding the high prevalence of diabetes in U. S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care 2014;37:1621-1628
84. Jainandunsing S, Özcan B, Rietveld T, et al. Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes. Acta Diabetol 2015;52:11-19
85. Lukacs JR, Pal JN. Skeletal variation among Mesolithic people of the Ganga Plains: new evidence of habitual activity and adaptation to climate. Asian Perspect 2003;42:329-351
86. Victora CG, de Onis M, Hallal PC, Blössner M, Shrimpton R. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics. 2010;125:e473-480
87. Stein AD, Wang M, Martorell R, et al.; Cohorts Group. Growth patterns inearlychildhood and final attained stature: data from five birth cohorts from low- and middle-income countries. Am J Hum Biol 2010;22:353-359
88. Hanafi MY, Saleh MM, Saad MI, Abdelkhalek TM, Kamel MA. Transgenerational effects of obesity and malnourishment on diabetes risk in F2 generation. Mol Cell Biochem 2016;412:269-280
89. Hardikar AA, Satoor SN, Karandikar MS, et al. Multigenerational undernutrition increases susceptibility to obesity and diabetes that is not reversed after dietary recuperation. Cell Metab 2015;22:312-319
90. Jaacks LM, Ali MK, Bartlett J, et al. Global noncommunicable disease research: opportunities and challenges. Ann Intern Med 2015;163:712-714
91. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases-where worlds meet. N Engl J Med 2010;363:1196-1198
92. Narayan KM, Ali MK, del Rio C, Koplan JP, Curran J. Global noncommunicable diseases-lessons from the HIV-AIDS experience. N Engl J Med 2011;365:876-878
93. Richmond G. Global science engagement. Science 2016;351:427
94. Centers for Disease Control and Prevention. Data and statistics, diabetes [Internet]. Available from http://www.cdc.gov/diabetes/data/. Accessed 16 February 2016
95. Worldmapper. The world as you've never seen it before [Internet]. Available from http://www.worldmapper.org/. Accessed 25 January 2016
96. Pavkov ME, Hanson RL, Knowler WC, Bennett PH, Krakoff J, Nelson RG. Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care 2007;30:1758-1763
97. Staimez LR, Deepa M, Ali MK, Mohan V, Narayan KM, Hanson RL. The tale of two Indians: a comparison of beta-cell function and insulin resistance between Pima Indians and Asian Indians [Abstract]. Diabetes 2014;63(Suppl. 1):A400